Valuation : Precision Therapeutics Inc

Market Cap 124M 107M 100M 91.47M 171M 11.69B 172M 1.18B 459M 5.99B 464M 454M 19.32B P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 115M 98.65M 92.67M 84.72M 159M 10.82B 159M 1.1B 425M 5.55B 430M 421M 17.9B EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript : Precision Therapeutics Inc

Manager TitleAgeSince
Chief Executive Officer 57 2026-02-08
Director of Finance/CFO - 2026-04-15
President - 2026-03-31
Director TitleAgeSince
Director/Board Member 66 2020-02-18
Chairman 78 2026-02-08
Director/Board Member 60 2020-07-08
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 124M
-2.54%-2.84%-1.90%+14.52% 48.93B
-0.40%+1.03%+439.20%+499.20% 45.01B
-1.42%+2.30%+45.46%+19.36% 44.07B
-1.22%-2.31%+12.40%+71.48% 40.73B
+0.53%-1.36%+16.04%+48.23% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+22.59%+116.19% 16.5B
-1.01%+0.50%+15.83%+27.98% 14.67B
-1.65%-1.03%+77.75%+37.63% 13.77B
Average -1.58%+0.53%+78.42%+104.33% 30.55B
Weighted average by Cap. -1.04%+0.11%+94.86%+122.11%

Financials

2024 2025
Net sales 1.62M 1.4M 1.31M 1.2M 2.25M 153M 2.25M 15.53M 6.02M 78.63M 6.1M 5.96M 254M 125K 108K 101K 92.66K 173K 11.84M 174K 1.2M 465K 6.07M 470K 460K 19.57M
Net income -12.66M -10.91M -10.25M -9.37M -17.52M -1.2B -17.58M -121M -46.96M -613M -47.55M -46.52M -1.98B -233M -201M -189M -172M -323M -22.03B -324M -2.23B -864M -11.29B -875M -856M -36.41B
Net Debt 1.4M 1.2M 1.13M 1.03M 1.93M 132M 1.94M 13.35M 5.18M 67.62M 5.24M 5.13M 218M -9.12M -7.86M -7.38M -6.75M -12.63M -862M -12.67M -87.27M -33.83M -442M -34.26M -33.51M -1.43B
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-